Literature DB >> 3057673

Pneumococcal vaccine.

R T White1.   

Abstract

Mesh：

Substances：

Year:  1988        PMID： 3057673      PMCID： PMC461242          DOI： 10.1136/thx.43.5.345

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  35 in total

1.  Maxwell Finland Lecture. Random gleanings from a life with the pneumococcus.

Authors:  R Austrian
Journal:  J Infect Dis       Date:  1975-04       Impact factor: 5.226

2.  Vaccination and revaccination with polyvalent pneumococcal polysaccharide vaccines in adults and infants.

Authors:  J M Borgoño; A A McLean; P P Vella; A F Woodhour; I Canepa; W L Davidson; M R Hilleman
Journal:  Proc Soc Exp Biol Med       Date:  1978-01

3.  Protective efficacy of pneumococcal polysaccharide vaccines.

Authors:  P Smit; D Oberholzer; S Hayden-Smith; H J Koornhof; M R Hilleman
Journal:  JAMA       Date:  1977-12-12       Impact factor: 56.272

4.  Polyvalent pneumococcal-polysaccharide immunization of patients with sickle-cell anemia and patients with splenectomy.

Authors:  A J Ammann; J Addiego; D W Wara; B Lubin; W B Smith; W C Mentzer
Journal:  N Engl J Med       Date:  1977-10-27       Impact factor: 91.245

5.  Pneumococcal vaccine failure.

Authors: 
Journal:  N Engl J Med       Date:  1987-05-14       Impact factor: 91.245

6.  Prospective study of the aetiology and outcome of pneumonia in the community.

Authors:  M A Woodhead; J T Macfarlane; J S McCracken; D H Rose; R G Finch
Journal:  Lancet       Date:  1987-03-21       Impact factor: 79.321

7.  Immunisation with a polyvalent pneumococcal vaccine. Reduction of adult respiratory mortality in a New Guinea Highlands community.

Authors:  I D Riley; P I Tarr; M Andrews; M Pfeiffer; R Howard; P Challands; G Jennison
Journal:  Lancet       Date:  1977-06-25       Impact factor: 79.321

8.  Response to pneumococcal polysaccharide vaccine in patients with untreated Hodgkin's disease. Children's Cancer Study Group Report.

Authors:  J E Addiego; A J Ammann; G Schiffman; R Baehner; G Higgins; D Hammond
Journal:  Lancet       Date:  1980-08-30       Impact factor: 79.321

9.  Immunisation with a polyvalent pneumococcal vaccine. Effect of respiratory mortality in children living in the New Guinea highlands.

Authors:  I D Riley; F A Everingham; D E Smith; R M Douglas
Journal:  Arch Dis Child       Date:  1981-05       Impact factor: 3.791

10.  Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine.

Authors:  C V Broome; R R Facklam; D W Fraser
Journal:  N Engl J Med       Date:  1980-09-04       Impact factor: 91.245
View more
  3 in total

Review 1.  Vaccination against pneumococcal infection.

Authors:  N D Noah
Journal:  BMJ       Date:  1988-11-26

2.  A hospital study of community acquired pneumonia in the elderly.

Authors:  P Venkatesan; J Gladman; J T Macfarlane; D Barer; P Berman; W Kinnear; R G Finch
Journal:  Thorax       Date:  1990-04       Impact factor: 9.139

3.  Induction of mucosal immunity by pulmonary administration of a cell-targeting nanoparticle.

Authors:  Tomoaki Kurosaki; Yuki Katafuchi; Junya Hashizume; Hitomi Harasawa; Hiroo Nakagawa; Mikiro Nakashima; Tadahiro Nakamura; Chikamasa Yamashita; Hitoshi Sasaki; Yukinobu Kodama
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.